<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Causevic M</submitter><funding>Deutscher Akademischer Austauschdienst (DE)</funding><funding>Breuer Foundation Alzheimer Award</funding><funding>Helmholtz-Israel project</funding><funding>Ministarstvo Obrazovanja, Znanosti i Sporta</funding><funding>EU Joint Programme for Neurodegenerative Disease Research</funding><funding>Centers of Excellence in Neurodgeneration (CoEN) initiative</funding><funding>Hrvatska Zaklada za Znanost</funding><pagination>e0200344</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6034874</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13(7)</volume><pubmed_abstract>It is intriguing that a rare, inherited lysosomal storage disorder Niemann-Pick type C (NPC) shares similarities with Alzheimer's disease (AD). We have previously reported an enhanced processing of β-amyloid precursor protein (APP) by β-secretase (BACE1), a key enzyme in the pathogenesis of AD, in NPC1-null cells. In this work, we characterized regional and temporal expression and processing of the recently identified BACE1 substrates seizure protein 6 (Sez6) and seizure 6-like protein (Sez6L), and APP, in NPC1-/- (NPC1) and NPC1+/+ (wt) mouse brains. We analysed 4-weeks old brains to detect the earliest changes associated with NPC, and 10-weeks of age to identify changes at terminal disease stage. Sez6 and Sez6L were selected due to their predominant cleavage by BACE1, and their potential</pubmed_abstract><journal>PloS one</journal><pubmed_title>BACE1-cleavage of Sez6 and Sez6L is elevated in Niemann-Pick type C disease mouse brains.</pubmed_title><pmcid>PMC6034874</pmcid><funding_grant_id>RiModFTD</funding_grant_id><funding_grant_id>2016-2017.</funding_grant_id><funding_grant_id>IP-2016-06-2799</funding_grant_id><pubmed_authors>Cermak S</pubmed_authors><pubmed_authors>Havas D</pubmed_authors><pubmed_authors>Hecimovic S</pubmed_authors><pubmed_authors>Windisch M</pubmed_authors><pubmed_authors>McDonald J</pubmed_authors><pubmed_authors>Colombo A</pubmed_authors><pubmed_authors>Flunkert S</pubmed_authors><pubmed_authors>Malnar M</pubmed_authors><pubmed_authors>Vidatic L</pubmed_authors><pubmed_authors>Kuhn PH</pubmed_authors><pubmed_authors>Hutter-Paier B</pubmed_authors><pubmed_authors>Lichtenthaler SF</pubmed_authors><pubmed_authors>Causevic M</pubmed_authors><pubmed_authors>Dominko K</pubmed_authors><pubmed_authors>Pigoni M</pubmed_authors><pubmed_authors>Krainc D</pubmed_authors><pubmed_authors>Gunnersen JM</pubmed_authors><pubmed_authors>Tahirovic S</pubmed_authors></additional><is_claimable>false</is_claimable><name>BACE1-cleavage of Sez6 and Sez6L is elevated in Niemann-Pick type C disease mouse brains.</name><description>It is intriguing that a rare, inherited lysosomal storage disorder Niemann-Pick type C (NPC) shares similarities with Alzheimer's disease (AD). We have previously reported an enhanced processing of β-amyloid precursor protein (APP) by β-secretase (BACE1), a key enzyme in the pathogenesis of AD, in NPC1-null cells. In this work, we characterized regional and temporal expression and processing of the recently identified BACE1 substrates seizure protein 6 (Sez6) and seizure 6-like protein (Sez6L), and APP, in NPC1-/- (NPC1) and NPC1+/+ (wt) mouse brains. We analysed 4-weeks old brains to detect the earliest changes associated with NPC, and 10-weeks of age to identify changes at terminal disease stage. Sez6 and Sez6L were selected due to their predominant cleavage by BACE1, and their potential</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018</publication><modification>2025-04-18T17:31:21.864Z</modification><creation>2019-03-26T23:46:54Z</creation></dates><accession>S-EPMC6034874</accession><cross_references><pubmed>29979789</pubmed><doi>10.1371/journal.pone.0200344</doi></cross_references></HashMap>